GLP-1 weight loss results: what 35 lbs actually means clinically

What did @_xochitlrdz actually say?

Honestly? Nothing medically specific. The transcript captured in this video appears to be garbled audio or background noise rather than coherent speech about GLP-1 medications. What we do have is the caption: she's down 35 pounds and she's in the #glp1community hashtag, which tells us she's using or has used a GLP-1 receptor agonist for weight loss. The visual transformation is the claim here, not a verbal one. So this fact-check focuses on what that 35-pound loss in the GLP-1 context actually means, and whether the implicit narrative, that GLP-1 drugs produce meaningful, lasting weight loss, holds up to scrutiny.

To be clear: a creator sharing a personal progress update is not the same as making a clinical claim. But 53,800 viewers are drawing conclusions from this content, and those conclusions are worth examining.

Does the science back this up?

Yes, with caveats. GLP-1 receptor agonists do produce significant weight loss in most people who use them, and 35 pounds is within the range clinical trials have documented. But the story is more complicated than a before-and-after video suggests.

The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found that semaglutide 2.4mg produced an average weight loss of 14.9% of body weight over 68 weeks. For a 250-pound person, that's roughly 37 pounds. The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed tirzepatide achieving up to 22.5% body weight reduction. These are real, reproducible numbers from large randomized controlled trials.

What the trials also show: most of the weight returns when people stop the medication. A 2022 follow-up study (Wilding et al., 2022, Diabetes, Obesity and Metabolism) found participants regained two-thirds of their lost weight within a year of stopping semaglutide. Progress videos don't usually include that part.

What did they get wrong (or right)?

@_xochitlrdz didn't make specific clinical claims, so there's nothing factually incorrect to correct here. She said she has "a long way to go" and acknowledged incremental progress. That framing is actually more honest than a lot of GLP-1 content on TikTok, which tends toward dramatic before-and-after narratives that omit the hard parts.

What's missing from the broader conversation this video feeds into:

• GLP-1 medications typically require ongoing use to maintain results. This is not a one-and-done fix.
• Side effects, primarily nausea, vomiting, and gastrointestinal distress, affect a significant portion of users. The STEP trials reported nausea in roughly 44% of semaglutide users.
• Access and cost remain serious barriers. Without insurance coverage, semaglutide can cost over $1,000 per month. Compounded versions exist but are not equivalent to FDA-approved brand-name drugs and carry their own regulatory considerations.

Credit where it's due: she's not selling anything here. She's not giving dosing advice. That puts her ahead of a lot of GLP-1 content creators.

What should you actually know?

If you're watching this video and wondering whether GLP-1 drugs could work for you, here's the honest version: they probably can produce meaningful weight loss if you're a candidate, but the decision involves more than a TikTok transformation.

GLP-1 receptor agonists are FDA-approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition. They work by mimicking a gut hormone that slows gastric emptying, reduces appetite, and signals satiety to the brain. They are not appetite suppressants in the traditional stimulant sense, and they are not appropriate for everyone.

A licensed clinician should evaluate cardiovascular history, thyroid history (there is a black box warning for medullary thyroid carcinoma risk in animal studies, though causation in humans is not established), and whether the medication fits the individual's full clinical picture. Progress videos are inspiring. They are not medical consultations.

The bottom line

This video is a personal milestone post, not a health claim. The implicit message, that GLP-1 medications produce real weight loss results, is supported by strong clinical evidence. The parts the video doesn't show, the side effects, the cost, the likelihood of regain after stopping, the ongoing nature of treatment, are the parts that matter most to anyone considering this path. Celebrate the 35 pounds. Read the fine print too.